Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation
Yu-Hsuan Fu, Da‐Liang Ou, Yi-Ru Yang, K. W. Su, Chien‐Yuan Chen, Hwei‐Fang Tien, Zheng-Sheng Lai, Che-Kun James Shen, Hsiung‐Fei Chien, Liang‐In Lin
Topics & Concepts
CabozantinibK562 cellsCancer researchProtein kinase BPI3K/AKT/mTOR pathwayMyeloid leukemiaMAPK/ERK pathwayBiologyLeukemiaPhosphorylationCell biologyChemistrySignal transductionImmunologyVEGF receptorsAcute Myeloid Leukemia ResearchKruppel-like factors researchMyeloproliferative Neoplasms: Diagnosis and Treatment